Sigma’s Q1 helped by HPAPI sales
Demand for HPAPIs helped US life science and technology supplier Sigma-Aldrich to a positive set of first quarter financials.
Archives for April 25, 2010
ACRO funds research into CROs’ role in drug development
ACRO is aiming to increase recognition and analysis of the value CROs bring to drug development, spanning their role as strategic partners throughout the process, by funding academic research.
New Xcellerex CEO targets growth in revenues, clients
The incoming Xcellerex CEO plans to move the company from validation to penetration, boosting revenues and client base, and invest in the contract manufacturing side of the business.
Medpace buys device testing firm Symbios
US CRO Medpace has move into medical device trials with acquisition of Symbios Clinical in a bid to tap into what CEO August Troendle said was a growth area for the contract research sector.
Colorcon buys NP Pharma
Colorcon has acquired excipient business NP Pharm, adding sugar spheres to its portfolio and production capacity that will become “an integral part” of its manufacturing network.
CRL to buy WuXi for $1.6bn
Charles River Laboratories (CRL) is to acquire WuXi PharmaTech for $1.6bn (€1.2bn), creating a global CRO capable of offering fully integrated services from molecule creation to first-in-human testing.